What is Protara Therapeutics Inc?
, a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 155.77M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.